Education
He completed a fellowship in medical oncology at the University of Minnesota and then returned to Sloan Kettering to join the faculty in 1979.
He completed a fellowship in medical oncology at the University of Minnesota and then returned to Sloan Kettering to join the faculty in 1979.
In 1997 he was appointed chair of the Department of Medicine at Sloan-Kettering. Bosl earned his bachelor’s degree at John Carroll University, in Cleveland, Ohio, and his Doctor of Medicine at Creighton University School of Medicine in Omaha, Nebraska. He trained in internal medicine at The New York Hospital and worked at Memorial Sloan Kettering Cancer Center as chief medical resident.
At Memorial Sloan Kettering Cancer Center he has been director of the Oncology/Hematology training program, chief of the Genitourinary Oncology Service, head of the Division of Solid Tumor Oncology, and associate physician-in-chief before becoming chair of the Department of Medicine in February 1, 1997.
He also heads the Joachim Silbermann Family Program on Aging and Cancer and has received grants from the National Institute of Health to study the sharp increase of older adults developing this disease. Bosl is a specialist in the treatment of genitourinary tumors particularly in testicular cancer.
He is known for targeting a marker chromosome for German cell tumors. His studies investigate molecular targets of drug resistance in patients and developing dose-intensive chemotherapy and new chemotherapeutic agents, evaluating new combinations for patients with relapsing or resistant disease.
Some of his research is also centered on new therapie for head and neck cancers.
